We will begin clinical trials on December 12, 2023.

nonat Inc. Corporation has received approval from the Ethics Review Committee on Medical Research of the Graduate School of Medicine at Gifu University, and will begin clinical research.


Please see below for details and disclosure of results related to this study.

(keisuke)